Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy-Reference-Cited by-同舟云学术

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

Published:2011-06-17 Issue:10 Volume:96 Page:1470-1477
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Barragan E.,Montesinos P.,Camos M.,Gonzalez M.,Calasanz M. J.,Roman-Gomez J.,Gomez-Casares M. T.,Ayala R.,Lopez J.,Fuster O.,Colomer D.,Chillon C.,Larrayoz M. J.,Sanchez-Godoy P.,Gonzalez-Campos J.,Manso F.,Amador M. L.,Vellenga E.,Lowenberg B.,Sanz M. A.,

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of a Patient with Acute Promyelocytic Leukemia with Multiple Isolated Relapses in the Central Nervous System: A Case Report and Mini-Review of the Literature;Case Reports in Hematology;2024-05-03

2. Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia;International Journal of Hematology;2024-02-22

3. Effective treatment with Gilteritinib-based regimens for FLT3-mutant extramedullary relapse in acute promyelocytic leukemia;Hematology;2023-12-14

4. CLINICAL FEATURES OF FLT3 MUTATIONS IN ACUTE MYELOID LEUKEMIA CASES AND THE ROLE OF FLT3 INHIBITORS IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE;2022-11-29

5. Evolving of treatment paradigms and challenges in acute promyelocytic leukaemia: A real-world analysis of 1105 patients over the last three decades;Translational Oncology;2022-11